Idecabtagene vicleucel (ide-cel) retreatment response was characterized by poor activation, impaired cellular expansion, and limited cytolytic activity of chimeric antigen receptor (CAR) T cells
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
chimeric antigen receptor,cytolytic activity,retreatment response,ide-cel
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要